Literature DB >> 7814486

Detection of resistance due to inducible beta-lactamase in Enterobacter aerogenes and Enterobacter cloacae.

T W Huber1, J S Thomas.   

Abstract

Thirty-six of 36 strains of Enterobacter cloacae and E. aerogenes with inducible beta-lactamase developed resistance when cefoxitin (inducer) was added to cefuroxime disks. Constitutive beta-lactamase producers (n = 23) were all resistant to cefuroxime. Cefuroxime resistance correlated with the amount of induced or constitutive beta-lactamase. Cefuroxime was a better indicator of induced resistance than cefamandole, cefazolin, cephalothin, ceftriaxone, cefotaxime, ticarcillin with or without clavulanic acid, or cefotetan. Induction by addition of cefoxitin to disks occasionally reduced zone sizes but not enough to change interpretations for ceftazidime, ceftizoxime, aztreonam, cefoperazone with or without sulbactam, and piperacillin with or without tazobactam. Most enterobacters were resistant to cefmetazole. The cefoxitin inducer-cefuroxime indicator method can be used in routine clinical laboratories to detect latent resistance due to chromosomally mediated inducible beta-lactamase in enterobacters.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7814486      PMCID: PMC264087          DOI: 10.1128/jcm.32.10.2481-2486.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Criteria for disk susceptibility tests and quality control guidelines for the cefoperazone-sulbactam combination.

Authors:  A L Barry; R N Jones
Journal:  J Clin Microbiol       Date:  1988-01       Impact factor: 5.948

Review 2.  Microbial resistance to newer generation beta-lactam antibiotics: clinical and laboratory implications.

Authors:  C C Sanders; W E Sanders
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

3.  Effect of beta-lactamase induction on susceptibility to cephalosporins in Enterobacter cloacae and Serratia marcescens.

Authors:  K Okonogi; A Sugiura; M Kuno; E Higashide; M Kondo; A Imada
Journal:  J Antimicrob Chemother       Date:  1985-07       Impact factor: 5.790

Review 4.  Emergence of resistance during therapy with the newer beta-lactam antibiotics: role of inducible beta-lactamases and implications for the future.

Authors:  C C Sanders; W E Sanders
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

5.  In vitro evaluation of CENTA, a new beta-lactamase-susceptible chromogenic cephalosporin reagent.

Authors:  R N Jones; H W Wilson; W J Novick; A L Barry; C Thornsberry
Journal:  J Clin Microbiol       Date:  1982-05       Impact factor: 5.948

6.  Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases.

Authors:  C C Sanders; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1979-06       Impact factor: 5.191

Review 7.  beta-Lactam resistance amongst Enterobacter species.

Authors:  A F Ehrhardt; C C Sanders
Journal:  J Antimicrob Chemother       Date:  1993-11       Impact factor: 5.790

8.  Nonspecific induction of beta-lactamase in Enterobacter cloacae.

Authors:  W Cullmann; A Dalhoff; W Dick
Journal:  J Gen Microbiol       Date:  1984-07

9.  Chromosomal beta-lactamases of Enterobacter cloacae are responsible for resistance to third-generation cephalosporins.

Authors:  A H Seeberg; R M Tolxdorff-Neutzling; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

10.  Emergence of resistance to beta-lactam and aminoglycoside antibiotics during moxalactam therapy of Pseudomonas aeruginosa infections.

Authors:  L C Preheim; R G Penn; C C Sanders; R V Goering; D K Giger
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

View more
  7 in total

1.  Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum beta-lactamase to other members of the family enterobacteriaceae.

Authors:  C Neuwirth; E Siebor; J Lopez; A Pechinot; A Kazmierczak
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

2.  Prevalence of outer membrane porin alteration in beta-lactam-antibiotic-resistant Enterobacter aerogenes.

Authors:  R N Charrel; J M Pagès; P De Micco; M Mallea
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

3.  Epidemiological study of an outbreak due to multidrug-resistant Enterobacter aerogenes in a medical intensive care unit.

Authors:  C Arpin; C Coze; A M Rogues; J P Gachie; C Bebear; C Quentin
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

4.  Occurrence and transferability of beta-lactam resistance in Enterobacteriaceae isolated in Children's University Hospital in Bratislava.

Authors:  H Bujdáková; J Hanzen; S Jankovicová; J Klimácková; M Moravcíková; P Milosovic; D Michálková-Papajová; J Kallová; A Jakab; M Kettner
Journal:  Folia Microbiol (Praha)       Date:  2001       Impact factor: 2.099

5.  Extended-spectrum beta-lactamases in enterobacteriaceae in Buenos Aires, Argentina, public hospitals.

Authors:  M Quinteros; M Radice; N Gardella; M M Rodriguez; N Costa; D Korbenfeld; E Couto; G Gutkind
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

6.  Successive emergence of extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacter aerogenes isolates in a university hospital.

Authors:  M Biendo; B Canarelli; D Thomas; F Rousseau; F Hamdad; C Adjide; G Laurans; F Eb
Journal:  J Clin Microbiol       Date:  2008-01-30       Impact factor: 5.948

7.  Occurrence and phenotypic characteristics of extended-spectrum beta-lactamases among members of the family Enterobacteriaceae at the Tel-Aviv Medical Center (Israel) and evaluation of diagnostic tests.

Authors:  Shiri Navon-Venezia; Orly Hammer-Munz; David Schwartz; Dan Turner; Boris Kuzmenko; Yehuda Carmeli
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.